Women-led Impact VC Firm investing in health technologies with a gender and climate lens
661 University Ave, Mars Centre Toronto Canada M5G 1M1
2021
Cross-Border Impact Ventures (CBIV) is an Impact Venture Capital firm that invests in early-growth stage health technology companies commercializing medical devices, diagnostics, therapeutics, and digital health innovations and leveraging cutting-edge technologies like Artificial Intelligence and Machine Learning. All innovations CBIV finances are relevant to women, children, and adolescent health and are located in North America and Europe with the ability to scale technologies to Emerging Markets. CBIV's Women’s and Children’s Health Technology Fund II will invest in Series A/B commercial-stage companies that address the healthcare needs of women and children inclusively and globally with emphasis on healthcare areas where there are significant disparities related to the gender, age, race, wealth, or geography, including health conditions that are expected to become more prevalent or severe with climate change.
